Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-121441

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 7:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 16, 2016M1,549$0.00A95,829D
Common StockF1May 16, 2016M817$0.00A96,646D
Common StockMay 18, 2016S1,184$15.96D95,462D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—May 16, 2016M1,549D——Common Stock1,54910,839D
Restricted Stock UnitsF3,F6,F7—May 16, 2016M817D——Common Stock8176,266D

Explanation of responses